Pediatricians and screening for obesity with body mass index: does level of training matter?

Jennifer B Hillman1, Sarah D Corathers, Stephen E Wilson

  • 1Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center and University of Cincinnati School of Medicine, Cincinnati, OH 45236, USA. Jennifer.Hillman@cchmc.org

Insights

Pediatricians rarely screen children for obesity using body mass index (BMI) charts. Resident physicians were more likely than attending physicians to document and plot BMI, indicating a need for improved childhood obesity screening practices.

Area of Science:

  • Pediatrics
  • Public Health
  • Preventive Medicine

Background:

  • Childhood obesity is a growing epidemic in industrialized nations.
  • Annual screening using body mass index (BMI) is recommended for all children.
  • Adherence to BMI screening recommendations by pediatricians is not well-documented.

Purpose of the Study:

  • To determine the proportion of children screened for obesity using BMI.
  • To compare the likelihood of BMI documentation and plotting between attending and resident physicians.

Main Methods:

  • Systematic review of medical records from an urban academic pediatric practice.
  • Inclusion of children aged 5–11 years who presented for healthcare in 2004.
  • Logistic regression analysis to identify factors associated with BMI documentation.

Main Results:

  • Only 5.5% of records documented BMI, and 4.3% plotted BMI.
  • Resident physicians were significantly more likely to document (13.0% vs. 3.0%) and plot (9.0% vs. 2.7%) BMI compared to attending physicians.
  • Children with BMI ≥95th percentile were more likely to have their BMI documented and plotted.

Conclusions:

  • The utilization of BMI for childhood obesity screening in this academic pediatric practice was found to be very poor.
  • Resident physicians demonstrated higher rates of BMI documentation and plotting than attending physicians.
  • There is a critical need to improve adherence to childhood obesity screening guidelines in pediatric settings.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...